Unprecedented Benefit Seen in Worldwide Test of a Three-Drug Treatment for Multiple Myeloma

PHOENIX — In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led by investigators from Mayo Clinic. Their findings will be reported online Dec. 6 in the New England Journal of Medicine, [...]
Source: Mayo Clinic Arizona News - Category: Hospital Management Source Type: news